Net Income Summary of Medistim ASA

Medistim ASA's latest annual net income in 2023 was 103.82 Million NOK , down -8.91% from previous year.
Medistim ASA's latest quarterly net income in 2024 Q3 was 23.42 Million NOK , down -32.52% from previous quarter.
Medistim ASA reported an annual net income of 113.97 Million NOK in 2022, up 25.38% from previous year.
Medistim ASA reported an annual net income of 90.9 Million NOK in 2021, up 31.0% from previous year.
Medistim ASA reported a quarterly net income of 23.42 Million NOK for 2024 Q3, down -32.52% from previous quarter.
Medistim ASA reported a quarterly net income of 24.38 Million NOK for 2024 Q1, up 27.58% from previous quarter.

Annual Net Income Chart of Medistim ASA (2023 - 2004)

Historical Annual Net Income of Medistim ASA (2023 - 2004)

Year	Net Income	Net Income Growth
2023	103.82 Million NOK	-8.91%
2022	113.97 Million NOK	25.38%
2021	90.9 Million NOK	31.0%
2020	69.38 Million NOK	-1.31%
2019	70.3 Million NOK	23.22%
2018	57.05 Million NOK	19.93%
2017	47.57 Million NOK	21.68%
2016	39.09 Million NOK	-3.28%
2015	40.42 Million NOK	29.37%
2014	31.24 Million NOK	17.75%
2013	26.53 Million NOK	-12.27%
2012	30.24 Million NOK	95.29%
2011	15.48 Million NOK	-16.99%
2010	18.65 Million NOK	-33.07%
2009	27.87 Million NOK	105.91%
2008	13.53 Million NOK	-52.32%
2007	28.39 Million NOK	0.0%
2006	- NOK	0.0%
2005	- NOK	0.0%
2004	- NOK	0.0%

Year	Net Income	Net Income Growth
2024 Q2	34.72 Million NOK	42.42%
2024 Q3	23.42 Million NOK	-32.52%
2024 Q1	24.38 Million NOK	27.58%
2023 FY	103.82 Million NOK	-8.91%
2023 Q3	26.13 Million NOK	-20.61%
2023 Q4	19.1 Million NOK	-26.88%
2023 Q1	25.66 Million NOK	-20.97%
2023 Q2	32.91 Million NOK	28.25%
2022 Q1	23.72 Million NOK	47.25%
2022 Q3	24.64 Million NOK	-25.59%
2022 Q4	32.47 Million NOK	31.77%
2022 FY	113.97 Million NOK	25.38%
2022 Q2	33.12 Million NOK	39.62%
2021 Q4	16.11 Million NOK	-14.29%
2021 FY	90.9 Million NOK	31.0%
2021 Q2	34.16 Million NOK	56.58%
2021 Q1	21.82 Million NOK	60.8%
2021 Q3	18.79 Million NOK	-44.98%
2020 FY	69.38 Million NOK	-1.31%
2020 Q1	21.1 Million NOK	36.28%
2020 Q2	20.26 Million NOK	-3.97%
2020 Q3	14.44 Million NOK	-28.75%
2020 Q4	13.57 Million NOK	-6.04%
2019 Q1	15.97 Million NOK	-33.15%
2019 Q2	22.12 Million NOK	38.56%
2019 FY	70.3 Million NOK	23.22%
2019 Q4	15.48 Million NOK	-7.35%
2019 Q3	16.71 Million NOK	-24.46%
2018 Q4	23.89 Million NOK	116.68%
2018 Q2	12.69 Million NOK	34.4%
2018 Q1	9.44 Million NOK	-24.31%
2018 FY	57.05 Million NOK	19.93%
2018 Q3	11.02 Million NOK	-13.13%
2017 Q4	12.47 Million NOK	-7.01%
2017 Q2	9.82 Million NOK	-17.18%
2017 FY	47.57 Million NOK	21.68%
2017 Q3	13.41 Million NOK	36.6%
2017 Q1	11.85 Million NOK	103.03%
2016 Q1	9.5 Million NOK	-22.23%
2016 FY	39.09 Million NOK	-3.28%
2016 Q4	5.84 Million NOK	-47.99%
2016 Q3	11.23 Million NOK	-10.28%
2016 Q2	12.51 Million NOK	31.63%
2015 Q1	7.41 Million NOK	-32.98%
2015 FY	40.42 Million NOK	29.37%
2015 Q4	12.22 Million NOK	18.51%
2015 Q3	10.31 Million NOK	-1.44%
2015 Q2	10.46 Million NOK	41.27%
2014 FY	31.24 Million NOK	17.75%
2014 Q4	11.05 Million NOK	41.27%
2014 Q3	7.82 Million NOK	9.35%
2014 Q2	7.15 Million NOK	37.57%
2014 Q1	5.2 Million NOK	-32.93%
2013 Q4	7.75 Million NOK	78.14%
2013 Q3	4.35 Million NOK	-49.76%
2013 FY	26.53 Million NOK	-12.27%
2013 Q2	8.66 Million NOK	50.69%
2013 Q1	5.75 Million NOK	256.89%
2012 Q2	6.8 Million NOK	8.39%
2012 Q3	15.54 Million NOK	128.29%
2012 Q4	1.61 Million NOK	-89.63%
2012 FY	30.24 Million NOK	95.29%
2012 Q1	6.28 Million NOK	194.24%
2011 Q4	2.13 Million NOK	-35.24%
2011 FY	15.48 Million NOK	-16.99%
2011 Q2	5.88 Million NOK	41.06%
2011 Q3	3.29 Million NOK	-43.98%
2011 Q1	4.17 Million NOK	-31.63%
2010 FY	18.65 Million NOK	-33.07%
2010 Q4	6.1 Million NOK	29.14%
2010 Q3	4.72 Million NOK	-14.39%
2010 Q2	5.51 Million NOK	138.92%
2010 Q1	2.31 Million NOK	-40.74%
2009 Q2	8.9 Million NOK	2.85%
2009 Q1	8.66 Million NOK	0.0%
2009 FY	27.87 Million NOK	105.91%
2009 Q4	3.89 Million NOK	-39.18%
2009 Q3	6.4 Million NOK	-28.05%
2008 FY	13.53 Million NOK	-52.32%
2007 FY	28.39 Million NOK	0.0%
2006 FY	- NOK	0.0%
2005 FY	- NOK	0.0%
2004 FY	- NOK	0.0%

Peer Net Income Comparison of Medistim ASA

Name	Net Income	Net Income Difference
Gentian Diagnostics ASA	-10.64 Million NOK	1075.047%
Lifecare AS	-35.25 Million NOK	394.465%

Global Stocks Search

Medistim ASA (MEDI.OL)

Net Income Summary of Medistim ASA

Annual Net Income Chart of Medistim ASA (2023 - 2004)

Historical Annual Net Income of Medistim ASA (2023 - 2004)

Peer Net Income Comparison of Medistim ASA